BGF Global Equity Income E2

Performance History30/09/2024
Growth of 1,000 (EUR)
BGF Global Equity Income E2
Fund-3.725.0-9.710.810.9
+/-Cat-0.1-1.1-3.61.0-2.4
+/-Idx--3.3-10.83.6-3.3
 
Key Stats
NAV
04/10/2024
 USD 23.53
Day Change 0.74%
Morningstar Category™ Global Equity Income
ISIN LU0545040122
Fund Size (Mil)
30/08/2024
 USD 976.91
Share Class Size (Mil)
04/10/2024
 USD 24.29
Max Initial Charge 3.00%
Ongoing Charge
15/04/2024
  2.31%
Investment Objective: BGF Global Equity Income E2
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed.
Returns
Trailing Returns (EUR)04/10/2024
YTD12.19
3 Years Annualised6.66
5 Years Annualised7.69
10 Years Annualised6.92
12 Month Yield 0.00
Management
Manager Name
Start Date
Olivia Treharne
01/02/2020
Molly Greenen
12/01/2022
Inception Date
20/05/2011
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
MSCI ACWI NR USDMorningstar Gbl High Div Yld NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeYes
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  BGF Global Equity Income E231/08/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks98.320.0098.32
Bonds0.020.000.02
Cash18.5216.861.65
Other0.000.000.00
Top 5 Regions%
United States62.69
Eurozone12.24
United Kingdom11.57
Europe - ex Euro7.26
Asia - Developed3.10
Top 5 Sectors%
Technology22.37
Industrials15.83
Financial Services14.91
Healthcare14.89
Consumer Defensive8.73
Top 5 HoldingsSector%
Microsoft CorpTechnologyTechnology4.91
AstraZeneca PLCHealthcareHealthcare3.17
Texas Instruments IncTechnologyTechnology3.17
Apple IncTechnologyTechnology3.14
Novo Nordisk AS Class BHealthcareHealthcare3.13
BGF Global Equity Income E2

Related

This fund has performance data calculated prior to the inception date of the fund. This is based upon a simulated/extended track record and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures